Get startedLog in
    Picture of Gubra A/S logo

    GUBRA — Gubra A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapContrarian
    All News

    Brief: Gubra Submits Clinical Trial Application For GUB-UCN2 In Germany

    Picture of Gubra A/S logoGubra A/S
    26/02/2026 06:31
    Feb 26 (Reuters) - Gubra A/S GUBRA.CO:

SUBMITS CLINICAL TRIAL APPLICATION FOR GUB-UCN2 IN GERMANY

GUB-UCN2 EXPECTED TO ENTER CLINICAL DEVELOPMENT IN FIRST HALF OF 2026

PHASE 1/2A TRIAL TO EVALUATE GUB-UCN2'S SAFETY AND EFFICACY

Source text: ID:nMFNXhZWB

Further company coverage: GUBRA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Gubra A/S

    See all news